Jasper Therapeutics (JSPR) Stock Chart & Stock Price History $5.55 +0.06 (+1.09%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Jasper Therapeutics Stock Price Performance The Jasper Therapeutics (JSPR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 76.02%, with a year-to-date return of -74.04%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Jasper Therapeutics traded at $5.55 with a market cap of $83.36 million and volume of 490,287 shares. Receive JSPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.46%1 Month Performance0.00%3 Month Performance+34.06%Year-To-Date Performance-74.04%1 Year Performance-76.02% JSPR Stock Chart for Tuesday, July, 1, 2025 JSPR Chart by TradingView Jasper Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/30/2025$5.49$5.55+1.09%$5.91$5.44490,287 shs$83.36 million06/27/2025$5.69$5.49-3.51%$5.86$5.351.98 million shs$82.46 million06/26/2025$5.57$5.69+2.15%$5.78$5.47162,711 shs$85.46 million06/25/2025$5.57$5.57$5.59$5.12223,479 shs$83.67 million06/24/2025$5.13$5.57+8.58%$5.72$5.06505,741 shs$83.66 million06/23/2025$5.15$5.13-0.39%$5.59$4.76571,606 shs$77.05 million06/20/2025$5.26$5.15-2.09%$5.48$5.01185,748 shs$77.36 million06/19/2025$5.26$5.26$5.51$5.23172,163 shs$79.01 million06/18/2025$5.41$5.26-2.77%$5.51$5.23172,163 shs$79.01 million06/17/2025$5.63$5.41-3.91%$5.80$5.41156,249 shs$81.27 million Get the Latest News and Ratings for JSPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/16/2025$5.58$5.63+0.90%$6.00$5.46289,468 shs$84.57 million06/13/2025$5.57$5.58+0.18%$5.65$5.43151,017 shs$83.82 million06/12/2025$5.60$5.57-0.54%$5.63$5.40159,835 shs$83.67 million06/11/2025$5.77$5.60-2.95%$5.94$5.55224,061 shs$84.12 million06/10/2025$5.94$5.77-2.86%$6.13$5.65248,826 shs$86.68 million06/09/2025$6.01$5.94-1.16%$6.10$5.86220,929 shs$89.23 million06/06/2025$5.70$6.01+5.44%$6.02$5.67316,372 shs$90.28 million06/05/2025$6.00$5.70-5.00%$6.03$5.56214,340 shs$85.63 million06/04/2025$5.90$6.00+1.69%$6.15$5.76229,156 shs$90.13 million06/03/2025$5.45$5.90+8.26%$6.20$5.46501,474 shs$88.63 million06/02/2025$5.55$5.45-1.80%$5.62$5.25177,789 shs$81.87 million05/30/2025$5.68$5.55-2.29%$5.80$5.23174,300 shs$83.37 million Related Companies Aardvark Therapeutics Stock Price Chart Olema Pharmaceuticals Stock Price Chart Aerovate Therapeutics Stock Price Chart Ocugen Stock Price Chart Monte Rosa Therapeutics Stock Price Chart Atea Pharmaceuticals Stock Price Chart Prime Medicine Stock Price Chart Alpha Teknova Stock Price Chart Rocket Pharmaceuticals Stock Price Chart Lifecore Biomedical Stock Price Chart Receive JSPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:JSPR) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
